GMF(SZ:002551) Shang Hai Zheng Quan Bao·2025-10-27 21:21Core Viewpoint - The company has disclosed its third-quarter financial report, ensuring the accuracy and completeness of the information provided, and has not undergone an audit for this report [2][3][16]. Financial Data - The company confirmed that there are no adjustments or restatements required for previous accounting data [3]. - The report indicates that there are no non-recurring gains or losses applicable [3]. - The company has reported a significant asset value of 176,701.89 million yuan for the main assets of the Xuchang Second Hospital, with a preliminary assessment value of 126,802.48 million yuan [9]. Shareholder Information - The report includes details on the total number of shareholders and the shareholding status of the top ten shareholders, although specific numbers are not provided [5]. Major Events - The company is involved in ongoing arbitration related to the Xuchang Second Hospital, with a total amount of 29,318.28 million yuan involved in the arbitration ruling [5][6]. - The company has faced challenges regarding the restructuring of the Xuchang Second Hospital, which has been delayed, potentially impacting its operational status [9]. - A transaction agreement was signed for the transfer of ownership of the Fuping Traditional Chinese Medicine Hospital, with a total transaction price of 21,425.03 million yuan [10]. Dividend Distribution - The company has approved a cash dividend distribution of 0.08 yuan per share, amounting to a total of 6,755,714.22 yuan, with the record date set for July 17, 2025 [11]. Legal Matters - The company’s subsidiary, Anhui Shangrong, was involved in an arbitration case that has since been withdrawn by the applicant, eliminating any potential impact on the company's profits [12][14].